Trial Profile
The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 03 Sep 2014
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- 24 Jun 2014 New trial record